Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1989 | 12-1988 | 12-1987 | 12-1986 | 12-1985 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,115 | 505 | -4,495 | N/A | N/A |
| Depreciation Amortization | 78 | 607 | 605 | N/A | N/A |
| Other Working Capital | -2,680 | N/A | N/A | N/A | N/A |
| Other Operating Activity | 239 | 3,525 | -234 | 0 | 0 |
| Operating Cash Flow | $-4,477 | $4,637 | $-4,124 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -170 | N/A | N/A | N/A | N/A |
| Net Acquisitions | 2,057 | 12 | -223 | N/A | N/A |
| Other Investing Activity | 1,080 | 14,514 | 208 | 0 | 0 |
| Investing Cash Flow | $2,967 | $14,526 | $-15 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | N/A | 11,428 | N/A | N/A | N/A |
| Other Financing Activity | 1,204 | 24,611 | -6,043 | 0 | 0 |
| Financing Cash Flow | $1,204 | $36,039 | $-6,043 | $N/A | $N/A |
| Beginning Cash Position | 3,313 | 16,392 | -1,680 | N/A | N/A |
| End Cash Position | 3,007 | 3,255 | -2,682 | N/A | N/A |
| Net Cash Flow | $-306 | $55,202 | $-10,182 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,477 | 4,637 | -4,124 | N/A | N/A |
| Free Cash Flow | -4,477 | 4,637 | -4,124 | 0 | 0 |